RXi Pharmaceuticals Corp 4
4 · RXi Pharmaceuticals Corp · Filed Jun 3, 2015
Insider Transaction Report
Form 4
Lockshin Curtis
Director
Transactions
- Award
Common stock, $0.0001 par value
2015-06-02$0.40/sh+12,000$4,800→ 13,000 total - Award
Common stock warrant
2015-06-02+6,000→ 6,000 totalExercise: $0.52From: 2015-06-02Exp: 2020-06-02→ Common stock (6,000 underlying) - Award
Overallotment purchase right
2015-06-02+6,000→ 6,000 totalExercise: $0.46From: 2015-06-02Exp: 2016-07-02→ Common stock (6,000 underlying)